IDE and vascular dementia: CK has also shown positive effects on vascular dementia by reducing the Amyloid β1-42 deposition caused by chronic cerebral hypoperfusion and improving cognitive impairment through the upregulation of pSer9-Glycogen synthase kinase 3β (pSer9-GSK3β) and the insulin degrading enzyme (IDE) [31].